Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (27)

2022

  1. Bayesian interpretation of immunotherapy trials with dynamic treatment effects

    European Journal of Cancer, Vol. 161, pp. 79-89

2021

  1. Erratum to “Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings” [Eur J Cancer 136 (September 2020) 159−168] (European Journal of Cancer (2020) 136 (159–168), (S0959804920303300), (10.1016/j.ejca.2020.06.003))

    European Journal of Cancer

2020

  1. A Trial of Lopinavir-Ritonavir in Covid-19

    The New England journal of medicine

  2. Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings

    European Journal of Cancer, Vol. 136, pp. 159-168

  3. Does active smoking worsen Covid-19?

    European Journal of Internal Medicine

2019

  1. Effect of risk of malnutrition on 30-day mortality among older patients with acute heart failure in Emergency Departments

    European Journal of Internal Medicine, Vol. 65, pp. 69-77

2018

  1. The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism

    Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 230-242

  2. Therapeutic approach for patients with eenous thromboembolism attended in emergency departments during routine clinical practice: The EDITH study

    Journal of Comparative Effectiveness Research, Vol. 7, Núm. 4, pp. 319-330

  3. Top ten errors of statistical analysis in observational studies for cancer research

    Clinical and Translational Oncology, Vol. 20, Núm. 8, pp. 954-965

2017

  1. Chronic opioid therapy in long-term cancer survivors

    Clinical and Translational Oncology, Vol. 19, Núm. 2, pp. 236-250

  2. Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

    Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237

  3. FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence

    Clinical and Translational Oncology, Vol. 19, Núm. 8, pp. 997-1009

  4. Malnutrition in children admitted to hospital. Results of a national survey

    Anales de Pediatria, Vol. 86, Núm. 5, pp. 270-276

  5. Nutrición parenteral domiciliaria en españa 2016; informe del grupo de nutrición artificial domiciliaria y ambulatoria nadya

    Nutricion Hospitalaria, Vol. 34, Núm. 6, pp. 1497-1501

  6. Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumors

    Clinical and Translational Oncology, Vol. 19, Núm. 3, pp. 386-395

  7. Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer

    Gastric Cancer, Vol. 20, Núm. 3, pp. 465-474

  8. Prognostic value of computed tomography pulmonary angiography indices in patients with cancer-related pulmonary embolism: Data from a multicenter cohort study

    European Journal of Radiology, Vol. 87, pp. 66-75

  9. Risk profile, management, and outcomes of patients with venous thromboembolism attended in Spanish Emergency Departments

    Medicine (United States), Vol. 96, Núm. 48

2016

  1. A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia

    British Journal of Cancer, Vol. 114, Núm. 11, pp. 1191-1198

  2. Teduglutida: Revisión de su uso en el síndrome de intestino corto

    Nutricion Hospitalaria, Vol. 33, Núm. 4, pp. 969-977